Approval · Notice of Compliance 6217 · 2005
NUTROPIN: Notice of Compliance 6217
Issued January 27, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6217
- Date
- January 27, 2005
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of dosing for adult patients
- Therapeutic class
- Growth hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUTROPIN | Not yet assigned | — |
| NUTROPIN AQ | Not yet assigned | — |
Medicinal ingredients
- SOMATROPIN 5 MG per VIAL
- SOMATROPIN 10 MG per VIAL
- SOMATROPIN 10 MG per 2ML
- SOMATROPIN 5 MG per 1ML